A phase II, dose finding study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of NS-065/NCNP-01 in boys with Duchenne muscular dystrophy

Authors:

Clemens P, Rao V, Connolly A, Harper A, Mah J, Smith E, McDonald C, Morgenroth L, Osaki H, Hoffman E

Citation:

Neuromusc Disord. 2018;28(Suppl 2):S67-S68. doi:10.1016/j.nmd.2018.06.156

Abstract:

no abstract available

Epub:

Not Epub

Link to Publication:

https://www.nmd-journal.com/article/S0960-8966(18)30720-X/fulltext

Organism or Cell Type:

human

Delivery Method:

i.v. infusion

You are here